Metropolitan Life Insurance Company (MetLife)’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,178	Closed	-$86K	–	2499
2017 Q4	$86K	Sell	1,178 -625	-35%	-$51.7K	﹤0.01%	2392
2017 Q3	$165K	Buy	+1,803	New	+$138K	﹤0.01%	2356
2017 Q2	–	Sell	-1,803	Closed	-$391K	–	2593
2017 Q1	$391K	Hold	1,803	–	–	﹤0.01%	1829
2016 Q4	$167K	Hold	1,803	–	–	﹤0.01%	2457
2016 Q3	$244K	Hold	1,803	–	–	﹤0.01%	2218
2016 Q2	$183K	Hold	1,803	–	–	﹤0.01%	2379
2016 Q1	$295K	Hold	1,803	–	–	﹤0.01%	1907
2015 Q4	$590K	Buy	1,803 +261	+17%	+$85K	﹤0.01%	1517
2015 Q3	$497K	Hold	1,542	–	–	﹤0.01%	1642
2015 Q2	$614K	Buy	+1,542	New	+$655K	﹤0.01%	1607
2015 Q1	–	Sell	-1,620	Closed	-$580K	–	2470
2014 Q4	$580K	Buy	1,620 +71	+5%	+$21.1K	﹤0.01%	1670
2014 Q3	$299K	Hold	1,549	–	–	﹤0.01%	2080
2014 Q2	$370K	Hold	1,549	–	–	﹤0.01%	2057
2014 Q1	$396K	Sell	1,549 -398	-20%	-$122K	﹤0.01%	1976
2013 Q4	$386K	Buy	1,947 +690	+55%	+$123K	﹤0.01%	1993
2013 Q3	$212K	Hold	1,257	–	–	﹤0.01%	2383
2013 Q2	$223K	Buy	+1,257	New	+$178K	﹤0.01%	2276

Other funds holding LUMO

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s LUMO Position: Q1 2018 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2018, closing a stake of 1,178 shares — an estimated $86K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in LUMO in Q2 2013 and held it in 17 quarters. The position peaked at $614K in Q2 2015. 126 funds tracked by Wall St. Rank hold LUMO as of Q1 2018.

Metropolitan Life Insurance Company (MetLife) reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 1,178 Lumos Pharma, Inc. Common Stock shares in Q1 2018, an estimated $86K.
Metropolitan Life Insurance Company (MetLife) first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 17 quarters.
Metropolitan Life Insurance Company (MetLife)'s Lumos Pharma, Inc. Common Stock position peaked at $614K in Q2 2015.
126 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2018.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2018, filed 15 May 2018.